LakeShore Biopharma Ltd Statistics Share Statistics LakeShore Biopharma Ltd has 41.21M
shares outstanding. The number of shares has increased by -90%
in one year.
Shares Outstanding 41.21M Shares Change (YoY) -90% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 9M Failed to Deliver (FTD) Shares 364 FTD / Avg. Volume 0.12%
Short Selling Information The latest short interest is 56.65K, so 0.14% of the outstanding
shares have been sold short.
Short Interest 56.65K Short % of Shares Out 0.14% Short % of Float 0.22% Short Ratio (days to cover) 1.03
Valuation Ratios PE Ratio 0 Forward PE 0.6 PS Ratio 0 Forward PS 0.2 PB Ratio 0 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for LakeShore Biopharma Ltd.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.02,
with a Debt / Equity ratio of 0.83.
Current Ratio 1.02 Quick Ratio 0.75 Debt / Equity 0.83 Debt / EBITDA -8.54 Debt / FCF -2.98 Interest Coverage -5.48
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $811.29K Profits Per Employee $-131.9K Employee Count 758 Asset Turnover 0.45 Inventory Turnover 0.47
Taxes Income Tax -946.87K Effective Tax Rate 0.94%
Stock Price Statistics The stock price has increased by -81.33% in the
last 52 weeks. The beta is 0.57, so LakeShore Biopharma Ltd's
price volatility has been higher than the market average.
Beta 0.57 52-Week Price Change -81.33% 50-Day Moving Average 0.92 200-Day Moving Average 1.77 Relative Strength Index (RSI) 48.85 Average Volume (20 Days) 310,435
Income Statement In the last 12 months, LakeShore Biopharma Ltd had revenue of 614.96M
and earned -99.98M
in profits. Earnings per share was -0.94.
Revenue 614.96M Gross Profit 507.19M Operating Income -86.29M Net Income -99.98M EBITDA -48.54M EBIT -85.19M Earnings Per Share (EPS) -0.94
Full Income Statement Balance Sheet The company has 28.08M in cash and 414.4M in
debt, giving a net cash position of -386.32M.
Cash & Cash Equivalents 28.08M Total Debt 414.4M Net Cash -386.32M Retained Earnings -2.41B Total Assets 1.37B Working Capital 17.47M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -120.98M
and capital expenditures -17.86M, giving a free cash flow of -138.84M.
Operating Cash Flow -120.98M Capital Expenditures -17.86M Free Cash Flow -138.84M FCF Per Share 0
Full Cash Flow Statement Margins Gross margin is 82.47%, with operating and profit margins of -14.03% and -16.26%.
Gross Margin 82.47% Operating Margin -14.03% Pretax Margin -16.41% Profit Margin -16.26% EBITDA Margin -7.89% EBIT Margin -14.03% FCF Margin -22.58%
Dividends & Yields LSB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for LSB.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 4, 2024. It was a
backward
split with a ratio of 1:10.
Last Split Date Oct 4, 2024 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -2.85 Piotroski F-Score 2
